Japan approves AI software that uses MRI scans to identify depression, aiming to make diagnosis more objective.
Key Details
- 1AI algorithm detects signs of depression by analyzing MRI brain scans.
- 2Developed by the Advanced Telecommunications Research Institute International in Japan.
- 3Software provides visual evidence of brain activity alterations linked to depression.
- 4Regulatory approval granted in Japan; type not specified (likely a medical device approval).
- 5Conventional depression diagnoses typically rely on subjective patient reports and interviews.
Why It Matters
Objective tools for diagnosing depression could improve accuracy, standardization, and treatment selection in mental health care. The approval highlights expanding clinical roles for imaging AI, especially in neuropsychiatric applications.
Source
Health Imaging
Related News
•AuntMinnie
GPT-4o AI Matches Radiologists in Follow-Up Imaging Recommendations
GPT-4o matched the performance of experienced radiologists and surpassed residents in recommending follow-up imaging from routine radiology reports.
•AuntMinnie
FDA Rejects Petition to Exempt Radiology AI Devices from 510(k) Review
FDA denies a petition to exempt certain radiology AI software from 510(k) review, stressing ongoing regulatory oversight.
•AuntMinnie
LLM Boosts Accuracy and Clarity of Patient Radiology Report Translations
A study found GPT-o1 effectively simplified and accurately translated emergency radiology reports into multiple languages, outperforming Google Translate.